184 related articles for article (PubMed ID: 34257747)
1. Peripheral Oxidation Markers in Down Syndrome Patients: The Better and the Worse.
Szwajgier D; Baranowska-Wójcik E; Grzelczyk J; Żukiewicz-Sobczak W
Dis Markers; 2021; 2021():5581139. PubMed ID: 34257747
[TBL] [Abstract][Full Text] [Related]
2. Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome.
Cenini G; Dowling AL; Beckett TL; Barone E; Mancuso C; Murphy MP; Levine H; Lott IT; Schmitt FA; Butterfield DA; Head E
Biochim Biophys Acta; 2012 Feb; 1822(2):130-8. PubMed ID: 22009041
[TBL] [Abstract][Full Text] [Related]
3. Increased oxidative stress biomarkers in the saliva of Down syndrome patients.
Komatsu T; Duckyoung Y; Ito A; Kurosawa K; Maehata Y; Kubodera T; Ikeda M; Lee MC
Arch Oral Biol; 2013 Sep; 58(9):1246-50. PubMed ID: 23714170
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and metabolism at rest and during exercise in persons with Down syndrome.
Flore P; Bricout VA; van Biesen D; Guinot M; Laporte F; Pépin JL; Eberhard Y; Favre-Juvin A; Wuyam B; van de Vliet P; Faure P
Eur J Cardiovasc Prev Rehabil; 2008 Feb; 15(1):35-42. PubMed ID: 18277183
[TBL] [Abstract][Full Text] [Related]
5. Lipid peroxidation in Down syndrome caused by regular trisomy 21, trisomy 21 by Robertsonian translocation and mosaic trisomy 21.
Casado A; López-Fernández ME; Ruíz R
Clin Chem Lab Med; 2007; 45(1):59-62. PubMed ID: 17243916
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress and Down syndrome. Do antioxidants play a role in therapy?
Muchová J; Žitňanová I; Ďuračková Z
Physiol Res; 2014; 63(5):535-42. PubMed ID: 24908086
[TBL] [Abstract][Full Text] [Related]
7. The exercise redox paradigm in the Down's syndrome: improvements in motor function and increases in blood oxidative status in young adults.
Aguiar AS; Tuon T; Albuquerque MM; Rocha GS; Speck AE; Araújo JC; Dafré AL; Prediger RD; Pinho RA
J Neural Transm (Vienna); 2008 Dec; 115(12):1643-50. PubMed ID: 18795225
[TBL] [Abstract][Full Text] [Related]
8. Coenzyme Q10 and oxidative imbalance in Down syndrome: biochemical and clinical aspects.
Tiano L; Padella L; Carnevali P; Gabrielli O; Bruge F; Principi F; Littarru GP
Biofactors; 2008; 32(1-4):161-7. PubMed ID: 19096112
[TBL] [Abstract][Full Text] [Related]
9. Down syndrome--genetic and nutritional aspects of accompanying disorders.
Mazurek D; Wyka J
Rocz Panstw Zakl Hig; 2015; 66(3):189-94. PubMed ID: 26400113
[TBL] [Abstract][Full Text] [Related]
10. Altered glutamate uptake in peripheral tissues from Down syndrome patients.
Begni B; Brighina L; Fumagalli L; Andreoni S; Castelli E; Francesconi C; Del Bo R; Bresolin N; Ferrarese C
Neurosci Lett; 2003 Jun; 343(2):73-6. PubMed ID: 12759167
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of urinary biomarkers of oxidative/nitrosative stress in adolescents and adults with Down syndrome.
Campos C; Guzmán R; López-Fernández E; Casado A
Biochim Biophys Acta; 2011 Jul; 1812(7):760-8. PubMed ID: 21447387
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant intervention attenuates oxidative stress in children and teenagers with Down syndrome.
Parisotto EB; Garlet TR; Cavalli VL; Zamoner A; da Rosa JS; Bastos J; Micke GA; Fröde TS; Pedrosa RC; Wilhelm Filho D
Res Dev Disabil; 2014 Jun; 35(6):1228-36. PubMed ID: 24685938
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of extracellular adenine nucleotides hydrolysis in platelets and biomarkers of oxidative stress in Down syndrome individuals.
Ferreira M; Rodrigues R; Motta E; Debom G; Soares F; de Mattos Bda S; Machado C; Stefanello FM; da Silva TM; Martins CC; Dalenogare D; Morsch VM; Braganhol E; Spanevello RM
Biomed Pharmacother; 2015 Aug; 74():200-5. PubMed ID: 26349985
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress occurs early in Down syndrome pregnancy: A redox proteomics analysis of amniotic fluid.
Perluigi M; di Domenico F; Fiorini A; Cocciolo A; Giorgi A; Foppoli C; Butterfield DA; Giorlandino M; Giorlandino C; Schininà ME; Coccia R
Proteomics Clin Appl; 2011 Apr; 5(3-4):167-78. PubMed ID: 21360684
[TBL] [Abstract][Full Text] [Related]
15. Exosomal biomarkers in Down syndrome and Alzheimer's disease.
Hamlett ED; Ledreux A; Potter H; Chial HJ; Patterson D; Espinosa JM; Bettcher BM; Granholm AC
Free Radic Biol Med; 2018 Jan; 114():110-121. PubMed ID: 28882786
[TBL] [Abstract][Full Text] [Related]
16. Persistence of the benefit of an antioxidant therapy in children and teenagers with Down syndrome.
Parisotto EB; Giaretta AG; Zamoner A; Moreira EA; Fröde TS; Pedrosa RC; Filho DW
Res Dev Disabil; 2015; 45-46():14-20. PubMed ID: 26207872
[TBL] [Abstract][Full Text] [Related]
17. Systemic oxidative stress in children and teenagers with Down syndrome.
Garlet TR; Parisotto EB; de Medeiros Gda S; Pereira LC; Moreira EA; Dalmarco EM; Dalmarco JB; Wilhelm Filho D
Life Sci; 2013 Oct; 93(16):558-63. PubMed ID: 24004546
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: insights from proteomics.
Perluigi M; Di Domenico F; Buttterfield DA
Proteomics Clin Appl; 2014 Feb; 8(1-2):73-85. PubMed ID: 24259517
[TBL] [Abstract][Full Text] [Related]
19. Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: redox proteomics analysis of human brain.
Di Domenico F; Coccia R; Cocciolo A; Murphy MP; Cenini G; Head E; Butterfield DA; Giorgi A; Schinina ME; Mancuso C; Cini C; Perluigi M
Biochim Biophys Acta; 2013 Aug; 1832(8):1249-59. PubMed ID: 23603808
[TBL] [Abstract][Full Text] [Related]
20. Systemic oxidative stress, as measured by urinary allantoin and F(2)-isoprostanes, is not increased in Down syndrome.
Tolun AA; Scarbrough PM; Zhang H; McKillop JA; Wang F; Kishnani PS; Millington DS; Young SP; Il'yasova D
Ann Epidemiol; 2012 Dec; 22(12):892-4. PubMed ID: 23063134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
